Concepedia

Chantal Reina-Ortiz

CR

6

Publications

662

Citations

6

H-Index

2008

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Institute for Regenerative Medicine & Biotherapy

Hospital Clínico Universitario Lozano Blesa

Instituto de Investigación Sanitaria Aragón

Inserm

Chantal Reina-Ortiz is an author at The University of Texas MD Anderson Cancer Center specializing in tumor microenvironment, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2008–2020

6

Publications

6

Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

Amy B. Heimberger, Mohamed Abou-Ghazal, Chantal Reina-Ortiz et al. · Clinical Cancer Research · 2008 · 328 citations

The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas

Mohamed Abou-Ghazal, David Yang, Wei Qiao et al. · Clinical Cancer Research · 2008 · 188 citations · Full text

Inhibition of p-STAT3 Enhances IFN-α Efficacy against Metastatic Melanoma in a Murine Model

Ling-Yuan Kong, Alexander Gelbard, Jun Wei et al. · Clinical Cancer Research · 2010 · 51 citations · Full text

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Chantal Reina-Ortiz, Michael G. Constantinides, Alexis Fayd’herbe de Maudave et al. · OncoImmunology · 2020 · 38 citations · Full text

Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance

Tania Calvo, Chantal Reina-Ortiz, David Giraldos et al. · Scientific Reports · 2020 · 36 citations · Full text

, , +18

Rows per page

1–5 of 6